Rozlytrek bags FDA approval
For the indication of ROS1-positive, metastatic non-small cell lung cancer (NSCLC).
Read More
Author: Anna Smith
£500,000 injected into ‘innovative’ AI online safety software
UK Meds has announced a partnership with Onfido to make buying prescription-only medicines online much safer.
Read More
Terlipressin hits phase III endpoint
CONFIRM is the largest-ever prospective study conducted in patients with hepatorenal syndrome type I.
Read More
Government to reconsider NHS Health Checks
The Health and Social Care Secretary has announced an evidence-based review into the service.
Read More
NHS toolkit launched for progressive neurological conditions
The NHS estimates there could be 2,500 fewer emergency admissions to hospital a year for patients with progressive neurological conditions.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
